Fats are hydrophobic hydrocarbon molecules consisting of fatty acids and glycerol. Glycerol has three carbons, each of which is attached to a hydroxyl group. Most fats are formed through replacement of the hydrogen of each hydroxyl group by a fatty acid. As three chains of fatty acids can be attached to each glycerol molecule, the resulting molecule is called a triglyceride.
Medium chain triglycerides (MCTs) are composed of fatty acids that contain between 6 and 12 carbon atoms compared to the 14 or more carbon atoms in long chain triglycerides (LCTs).
Fats can be further characterised by the number of double bonds in the fatty acid chain. Monounsaturated fatty acids (MUFAs) have one double bond in the chain, whereas polyunsaturated fatty acids (PUFAs) have more. Unsaturated fats are named according to the position of the double bonds: counting from the non-glycerol end of the fatty acid, the first double bond encountered in an omega-3 (?-3) fatty acid is at the third carbon.
Eicosanoids are signalling molecules made by oxygenation of twenty-carbon fatty acids.1
Some fatty acids that are released in the process of digestion are called essential because they cannot be synthesised in the body from simpler constituents: alpha-linolenic acid (an ?-3 fatty acid) and linoleic acid (an ?-6 fatty acid). Other lipids needed by the body can be synthesised from these and other fats. Fats and other lipids are broken down in the body by enzymes called lipases produced in the pancreas.
Fats provide energy for the body, and can be stored as adipose tissue when consumed in excess of immediate needs. Each gram of fat releases about 9 food calories (37 kJ = 8.8 kCal). Fats are broken down to release glycerol and fatty acids, and glycerol can be converted to glucose by the liver and so become a source of energy.
Vitamin transport and fats
Vitamins A, D, E, and K are fat-soluble, meaning they can only be digested, absorbed, and transported in conjunction with fats. Lipids are a key component of cell membranes, where they modulate membrane fluidity which affects membrane-bound receptors and enzymes.2 They are involved in precursor synthesis, provide the building blocks for synthesis of cholesterol and fat-soluble vitamins, and regulate blood pressure, blood clotting, inflammation and the corresponding immune response.
Eicosanoids exert complex control over many bodily systems, mainly in inflammation, immunity, and as messengers in the central nervous system. The networks of control that depend upon eicosanoids are among the most complex in the human body. There are three main subgroups of eicosanoid:
- Cytokines: signalling molecules used extensively in cellular communication
- Prostaglandins: a group of lipid compounds derived enzymatically from fatty acids.
- Leukotrienes: naturally produced eicosanoid lipid mediators, partly responsible for the effects of the inflammatory response.
In general, ?-6 fatty acids are pro-inflammatory and ?-3 fatty acids are anti-inflammatory.5 The common ?-3 and ?-6 fatty acids are shown in Figure 1.
|Outcome of Impairment
||Nutrients in the adult Peptamen® family
to Address Area of Impairment
|Feeding tolerance and malabsorption
- Faster gastric emptying
- 100% hydrolyzed whey protein hydrolysate (<1% intact protein)
- 50-70% MCT
|Meeting protein needs
- Loss of lean body mass
- 100% hydrolyzed Whey protein hydrolysate (<1% intact protein). Elevated protein needs- Peptamen® Intense VHP
- Decreased immune function
- Fish oil (Peptamen® AF and Peptamen® Intense)
- Cell membrane damage
- Organ dysfunction and damage
- ?-carotene, Vitamin C, Vitamin E, Selenium, and Zinc
|Modulate the intestinal microflora and promote gut integrity
- Prebio1™ (Inulin and FOS) – Peptamen® Intense VHP
?-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA )are found in cold-water fish. Increased levels lead to :
- displacement of ?-6 fatty acids from the cell membranes of immune cells, reducing systemic inflammation through the production of biologically less active prostaglandins and leukotrienes.6
- to modulation of systemic and local inflammation.6
- help stabilise the myocardium and lower the incidence of cardiac arrhythmias, decrease incidence of ARDS, and reduce likelihood of sepsis.6-8
Figure 2 shows the main pathway for the production of pro-inflammatory compounds from ?-6 fatty acids and anti-inflammatory compounds from ?-3 fatty acids.
Dietary fat is primarily consumed as triacylglycerol, while other forms include cholesterol and free fatty acids.
Recommendations for total fat intake in adults are set by the Daily Recommended Intakes. Fat should provide between 20 and 35% of calories for men and women aged over 30 years.9
The FAO/WHO 2008 recommend a total PUFA consumption of between 6 and 11% total energy (E) and also that saturated fatty acids (SFA) in the diet should be replaced by PUFAs (?-6 and ?-3).10
There should be a minimum intake of 2.5%E linoleic acid and 0.5%E a-linolenic acid to prevent deficiencies of essential fatty acids.10
Studies have not separated EPA and DHA intakes, so there is no specific recommendation for the single oils. The recommended intake for EPA+DHA is defined either as the amount of fish that should be consumed or the absolute quantities of EPA+DHA, typically between 250 and 600 mg/day.
The ratio of ?-6 : ?-3 fatty acids can affect the patient response to disease by favouring either the inflammatory or anti-inflammatory pathway of eicosanoid production.
Role of fats in illness
Fats are hydrophobic and are therefore emulsified by bile salts and phospholipids as a first stage in digestion. Pancreatic lipase works at the surface of the emulsified droplets to break them into monoglycerides and fatty acids which are then transported to the surface of the enterocyte. Once inside, the components are re-synthesised into chylomicrons before entering lymphatic capillaries and eventually the bloodstream.
MCTs are absorbed in the duodenum faster than LCTs, being taken directly into the portal system and transported to the liver without the need for bile salts, and are readily hydrolysed by pancreatic lipase.11,12
MCTs are not stored as adipose tissue, but are rapidly metabolised to ketone bodies, providing a readily available non-carbohydrate energy source. MCTs are thus a good energy source for patients with fat malabsorption.13
During times of malnutrition, stress or if the GI tract is compromised, LCT malabsorption is very common. Fat malabsorption is characterised by bulky, frothy, voluminous, loose stool, but can be improved by providing formulas rich in MCT oil to minimise risk of fat malabsorption.
Stress related to acute diseases and drugs may decrease GI motility and gastric emptying, increasing the risk of reflux and lung aspiration. MCTs are well tolerated, as they are emptied from the stomach faster than LCT.14 It has been shown that the absorption of unsaturated fatty acids is inversely proportional to their chain length.15
As MCTs are easily absorbed and hydrolysed they are suitable for malnourished patients with reduced lipase activity and bile production.16,17 MCTs also provide more readily available energy than LCTs. Enteral formulas containing 25 to 50% MCT are commonly used in patients requiring intensive clinical nutrition.18 This ensures a supply of essential fatty acids from the LCT and better digestion, absorption and metabolism due to the MCT.18-20
Fish oil is used to help control inflammation associated with critical and chronic illness.21 Typically, fish oil triglycerides contain one highly unsaturated fatty acid and two saturated fatty acids. The triglyceride is broken down to two free fatty acids and a monoglyceride for absorption from the GI tract. The fatty acids and monoglyceride are reassembled and transported in the body for use as ingredients for cell components, active molecules, or storage in adipose tissue as an energy reserve.22
In the critical care setting, the inflammatory response may be intentionally modulated to avoid excessive inflammation.
The typical western diet has a ?-6 : ?-3 fatty acid ratio of > 15:123 which is pro-inflammatory. There is no broad consensus on the optimal ?-6 : ?-3 ratio other than that a relatively low ratio is beneficial for the critically ill patient.
Fats in Enteral Nutrition
MCTs are an energy dense, well absorbed nutrient used to provide energy to patients suffering from impaired absorption of LCTs. MCTs are not considered to be essential nutrients, but are added to EN products to aid digestion,16 absorption in the upper portion of the small intestine.17 They are well tolerated when used in formulas that are designed to be readily absorbed,13 and do not require pancreatic lipase or bile for digestion and absorption.13 Typical levels range up to 70% of the lipid calories.
Some enteral formulas contain MUFAs and PUFAs for glycaemic benefit. MCTs are frequently used in nutrition therapy for cases of disturbed digestion, absorption, or transport of dietary fat.19
LCT digestion, absorption, and transport are more complex processes